Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05571189 · ClinicalTrials.gov registry record · NA

Home Rehabilitation After Acute Pulmonary Embolism

A NA study of Pulmonary Embolism, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT05571189 is a NA study of Pulmonary Embolism that has completed, run by University of Rochester. The registered enrollment target is 32 participants, below the 3,058-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05571189, a NA study of Pulmonary Embolism, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate whether a home rehabilitation program after hospitalization for acute pulmonary embolism (PE) improves clinical outcomes at 3 months compared to usual care. Daily physical activity tasks that incorporate heart rate monitoring will be sent through email or text. This information could help improve the management of acute PE.

Conditions Studied

Interventions

  • BEHAVIORAL Daily Activity Text
  • BEHAVIORAL Control Text

Study Locations (1)

New York

  • University of Rochester Medical Center - Rochester

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2022-12-19
Est. Completion 2025-09-24
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT05571189

The ClinicalTrials.gov registry entry for NCT05571189 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,058-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (99% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions - of which Daily Activity Text is the first listed.

NCT05571189 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05571189 about?

NCT05571189 is a clinical study titled "Home Rehabilitation After Acute Pulmonary Embolism". The purpose of this study is to evaluate whether a home rehabilitation program after hospitalization for acute pulmonary embolism (PE) improves clinical outcomes at 3 months compared to usual care. Daily physical activity tasks that incorporate heart rate monitoring will be sent through email or tex...

What is the current status of trial NCT05571189?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2022-12-19. Estimated completion is 2025-09-24.

What conditions does trial NCT05571189 study?

This clinical trial studies the following conditions: Pulmonary Embolism.

What interventions are being tested in trial NCT05571189?

The interventions under investigation include: Daily Activity Text (BEHAVIORAL), Control Text (BEHAVIORAL).

Who is sponsoring clinical trial NCT05571189?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05571189 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pulmonary Embolism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.